arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Arbutus Biopharma Corporation

ABUS Health Care Biotechnology: Pharmaceutical Preparations
$4.21
▲ +0.6% Today
as of Oct 23, 13:45 ET
Last 30 days -18.11% Sep 14 → Oct 23
$4.03 $4.32 $4.62 $4.92 $5.21 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.22
High
$4.37
Low
$4.17
Volume
$2M
Avg Vol
$3M
Mkt Cap
$902M
P/E (TTM)
5.27
Beta
—
52w High
$5.45
52w Low
$3.50
Div Yield
—
Shares Out
$198M

Recent Press Releases & News last 60 days · 4 items

Oct 22 · 12:10 MT Newswires
Arbutus Says US Lifts Clinical Hold on AB-101 Hepatitis B Drug
Oct 22 · 11:30 PR GlobeNewswire
Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Oct 1 · 11:30 PR GlobeNewswire
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
▸ Show all 4 press releases & news Free account →

ABUS earnings at a glance

The options market is pricing a move of about ±14.7% after the report, a range of roughly $3.59 to $4.83 from today's $4.21. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±0.5% on average; after the most recent report on May 13, 2026 it moved +0.0%. That means options currently expect more movement than ABUS has typically delivered. ABUS beat the consensus EPS estimate in 1 of its last 2 reported quarters. Implied volatility is currently 111%. The share price of $4.21 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.50
$5.45
36% of range
Avg surprise (last 2)
+52.8%
Avg reaction (last 2)
-0.5%
0% positive
Latest IV / EM
111%
EM ±14.7% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.13$0.12$0.37$0.62$0.87 Actual $-0.10Actual $-0.10Actual $-0.12Actual $-0.10Actual $-0.11Actual $-0.10Actual $-0.13Est $-0.09Actual $0.01Est $-0.02Actual $-0.04Actual $0.87Actual $-0.03 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-25M$29M$82M$135M$188M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.03 — — — — financials
Wed May 13, 2026Mar/2026 $0.87 — — +769.2% 0.0% earnings
Thu Nov 13, 2025Sep/2025 $-0.04 — — — — earnings
Wed Aug 6, 2025Jun/2025 $0.01 $-0.02 +150.0% — — earnings
Wed May 14, 2025Mar/2025 $-0.13 $-0.09 -44.4% — -0.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.10 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.11 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.10 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.12 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.10 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.10 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1M$179M—$529,000$11M$2M—$1M
Cost of revenue————————
Gross profit————————
Operating income$-6M$169M—$-9M$1M$-26M—$-21M
Net income$-5M$170M—$-8M$3M$-25M—$-20M
EPS (diluted)$-0.03$0.87—$-0.04$0.01$-0.13—$-0.10

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$19M$24M$18M$22M$37M$37M$36M$32M
Inventory————————
Total current assets$274M$277M$94M$97M$103M$117M$127M$133M
Total assets$274M$277M$95M$98M$103M$117M$132M$140M
Long-term debt$0$0—$0$0$0—$0
Total liabilities$15M$17M$18M$20M$20M$38M$34M$34M
Total equity$259M$260M$77M$77M$83M$79M$97M$107M

Implied volatility — last 90 days

23%152%281%411%540% Jun 07 — IV 102% · EM ±14.1%Jun 08 — IV 107% · EM ±14.2%Jun 09 — IV 291% · EM ±36.5%Jun 10 — IV 51% · EM ±6.1%Jun 11 — IV 53% · EM ±5.8%Jun 12 — IV 138% · EM ±14.1%Jun 17 — IV 541% · EM ±22.6%Jun 19 — IV 70% · EM ±15.4%Jun 22 — IV 62% · EM ±12.9%Jun 24 — IV 129% · EM ±25.8%Jun 30 — IV 51% · EM ±8.9%Jul 02 — IV 60% · EM ±9.8%Jul 03 — IV 62% · EM ±9.8%Jul 06 — IV 51% · EM ±7.0%Jul 07 — IV 95% · EM ±12.5%Jul 08 — IV 107% · EM ±13.4%Jul 09 — IV 91% · EM ±10.7%Jul 20 — IV 122% · EM ±28.9%Jul 21 — IV 24% · EM ±5.5%Jul 22 — IV 86% · EM ±19.6%Jul 24 — IV 124% · EM ±27.4%Jul 27 — IV 130% · EM ±27.1%Jul 28 — IV 150% · EM ±30.6%Jul 29 — IV 70% · EM ±14.0%Jul 30 — IV 84% · EM ±16.4%Jul 31 — IV 36% · EM ±6.9%Aug 04 — IV 125% · EM ±21.5%Aug 05 — IV 94% · EM ±15.7%Aug 06 — IV 34% · EM ±5.5%Aug 07 — IV 164% · EM ±25.6%Aug 10 — IV 110% · EM ±15.3%Aug 11 — IV 206% · EM ±27.2%Aug 12 — IV 113% · EM ±14.2%Aug 14 — IV 184% · EM ±20.3%Aug 18 — IV 243% · EM ±17.6%Aug 19 — IV 85% · EM ±5.0%Aug 20 — IV 226% · EM ±9.4%Aug 24 — IV 35% · EM ±7.2%Aug 25 — IV 35% · EM ±7.2%Aug 26 — IV 31% · EM ±6.3%Aug 27 — IV 32% · EM ±6.3%Aug 28 — IV 23% · EM ±4.4%Aug 31 — IV 28% · EM ±4.9%Sep 01 — IV 31% · EM ±5.4%Sep 03 — IV 48% · EM ±7.8%Sep 04 — IV 43% · EM ±6.8%Sep 07 — IV 49% · EM ±6.8%Sep 08 — IV 66% · EM ±8.7%Sep 09 — IV 54% · EM ±6.8%Sep 10 — IV 41% · EM ±4.9%Sep 11 — IV 53% · EM ±5.9%Sep 14 — IV 70% · EM ±5.8%Sep 15 — IV 41% · EM ±3.0%Sep 16 — IV 67% · EM ±4.0%Sep 17 — IV 71% · EM ±3.0%Sep 21 — IV 48% · EM ±10.0%Sep 22 — IV 46% · EM ±9.5%Sep 23 — IV 54% · EM ±10.8%Sep 24 — IV 58% · EM ±11.3%Sep 25 — IV 65% · EM ±12.4%Sep 28 — IV 75% · EM ±13.4%Sep 29 — IV 99% · EM ±17.1%Sep 30 — IV 38% · EM ±6.3%Oct 01 — IV 149% · EM ±24.1%Oct 02 — IV 137% · EM ±21.3%Oct 06 — IV 111% · EM ±14.7%

Sector peers

MLTX
MoonLake Immunotherapeutics
$917M $11.76+10.4%
TBPH
Theravance Biopharma, Inc.
$880M $17.030.0%
JBIO
Jade Biosciences, Inc.
$876M $14.79-2.2%
CRVS
Corvus Pharmaceuticals, Inc.
$876M $10.37+3.2%
HELP
Helus Pharma Inc.
$870M $9.96-7.6%
KURA
Kura Oncology, Inc.
$949M $9.59-3.0%

ABUS earnings FAQ

What is ABUS's expected move for earnings?

Options currently price a move of about ±14.7%, or $0.62 per share either way from $4.21.

How does ABUS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±0.5%, up 0 times and down 2 times.

What is ABUS's implied volatility?

ABUS's at-the-money implied volatility is about 111% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in